Sartorius Stedim Biotech S.A.
SDMHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,780 | $2,776 | $3,493 | $2,887 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Cost of Goods Sold | $1,573 | $1,542 | $1,658 | $1,334 |
| Gross Profit | $1,207 | $1,234 | $1,835 | $1,553 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| R&D Expenses | $144 | $130 | $132 | $110 |
| G&A Expenses | $169 | $167 | $155 | $126 |
| SG&A Expenses | $649 | $616 | $601 | $532 |
| Sales & Mktg Exp. | $480 | $449 | $447 | $406 |
| Other Operating Expenses | $44 | $0 | $2 | $2 |
| Operating Expenses | $836 | $771 | $752 | $670 |
| Operating Income | $371 | $450 | $995 | $865 |
| % Margin | 13.3% | 16.2% | 28.5% | 30% |
| Other Income/Exp. Net | -$151 | -$48 | $135 | -$219 |
| Pre-Tax Income | $219 | $401 | $1,130 | $647 |
| Tax Expense | $41 | $89 | $251 | $232 |
| Net Income | $175 | $310 | $876 | $414 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS | 1.81 | 3.36 | 9.51 | 4.5 |
| % Growth | -46.1% | -64.7% | 111.3% | – |
| EPS Diluted | 1.81 | 3.36 | 9.51 | 4.5 |
| Weighted Avg Shares Out | 97 | 92 | 92 | 92 |
| Weighted Avg Shares Out Dil | 97 | 92 | 92 | 92 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20 | $6 | $1 | $0 |
| Interest Expense | $164 | $117 | $19 | $10 |
| Depreciation & Amortization | $302 | $238 | $182 | $142 |
| EBITDA | $671 | $756 | $1,331 | $799 |
| % Margin | 24.1% | 27.2% | 38.1% | 27.7% |